More Needs To Be Done To Accelerate Device Reviews – von Eschenbach
This article was originally published in The Gray Sheet
Executive Summary
Acting FDA Commissioner Andrew von Eschenbach said the agency needs to go beyond the "incremental" improvements it has made in speeding up the review of device premarket applications under the Medical Device User Fee & Modernization Act (MDUFMA)